Teleflex’ Arrow Seldinger arterial catheterisation device received market clearance from the US Food and Drug Administration (FDA).
The new device is indicated for short-term use. The device is designed to improve patient safety by eliminating confusion of catheter identification, reduce risk of complications associated with insertion technique, and provide optimal diagnostics leading to effective treatment for patients. Multiple sizes are available to provide customiaation to each patient, each insertion site, and each application.
Jake Newman, vice president and general manager of Teleflex’s Vascular Access Division, says, “This…device is intended to facilitate ease of insertion and resistance to body collapse.”
Teleflex expects to launch Arrow Seldinger in the USA this year.
